Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.

Klughammer J, Kiesel B, Roetzer T, Fortelny N, Nemc A, Nenning KH, Furtner J, Sheffield NC, Datlinger P, Peter N, Nowosielski M, Augustin M, Mischkulnig M, Ströbel T, Alpar D, Ergüner B, Senekowitsch M, Moser P, Freyschlag CF, Kerschbaumer J, Thomé C, Grams AE, Stockhammer G, Kitzwoegerer M, Oberndorfer S, Marhold F, Weis S, Trenkler J, Buchroithner J, Pichler J, Haybaeck J, Krassnig S, Mahdy Ali K, von Campe G, Payer F, Sherif C, Preiser J, Hauser T, Winkler PA, Kleindienst W, Würtz F, Brandner-Kokalj T, Stultschnig M, Schweiger S, Dieckmann K, Preusser M, Langs G, Baumann B, Knosp E, Widhalm G, Marosi C, Hainfellner JA, Woehrer A, Bock C.

Nat Med. 2018 Oct;24(10):1611-1624. doi: 10.1038/s41591-018-0156-x. Epub 2018 Aug 27.

PMID:
30150718
2.

DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.

Sheffield NC, Pierron G, Klughammer J, Datlinger P, Schönegger A, Schuster M, Hadler J, Surdez D, Guillemot D, Lapouble E, Freneaux P, Champigneulle J, Bouvier R, Walder D, Ambros IM, Hutter C, Sorz E, Amaral AT, de Álava E, Schallmoser K, Strunk D, Rinner B, Liegl-Atzwanger B, Huppertz B, Leithner A, de Pinieux G, Terrier P, Laurence V, Michon J, Ladenstein R, Holter W, Windhager R, Dirksen U, Ambros PF, Delattre O, Kovar H, Bock C, Tomazou EM.

Nat Med. 2017 Mar;23(3):386-395. doi: 10.1038/nm.4273. Epub 2017 Jan 30.

3.

Pooled CRISPR screening with single-cell transcriptome readout.

Datlinger P, Rendeiro AF, Schmidl C, Krausgruber T, Traxler P, Klughammer J, Schuster LC, Kuchler A, Alpar D, Bock C.

Nat Methods. 2017 Mar;14(3):297-301. doi: 10.1038/nmeth.4177. Epub 2017 Jan 18.

4.

Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia.

Heller G, Topakian T, Altenberger C, Cerny-Reiterer S, Herndlhofer S, Ziegler B, Datlinger P, Byrgazov K, Bock C, Mannhalter C, Hörmann G, Sperr WR, Lion T, Zielinski CC, Valent P, Zöchbauer-Müller S.

Leukemia. 2016 Sep;30(9):1861-8. doi: 10.1038/leu.2016.143. Epub 2016 May 23.

5.

Differential DNA Methylation Analysis without a Reference Genome.

Klughammer J, Datlinger P, Printz D, Sheffield NC, Farlik M, Hadler J, Fritsch G, Bock C.

Cell Rep. 2015 Dec 22;13(11):2621-2633. doi: 10.1016/j.celrep.2015.11.024. Epub 2015 Dec 8.

6.

Imprinted expression in cystic embryoid bodies shows an embryonic and not an extra-embryonic pattern.

Kulinski TM, Casari MR, Guenzl PM, Wenzel D, Andergassen D, Hladik A, Datlinger P, Farlik M, Theussl HC, Penninger JM, Knapp S, Bock C, Barlow DP, Hudson QJ.

Dev Biol. 2015 Jun 15;402(2):291-305. doi: 10.1016/j.ydbio.2015.04.010. Epub 2015 Apr 24.

7.

Single-cell DNA methylome sequencing and bioinformatic inference of epigenomic cell-state dynamics.

Farlik M, Sheffield NC, Nuzzo A, Datlinger P, Schönegger A, Klughammer J, Bock C.

Cell Rep. 2015 Mar 3;10(8):1386-97. doi: 10.1016/j.celrep.2015.02.001. Epub 2015 Feb 26.

8.

Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1.

Tomazou EM, Sheffield NC, Schmidl C, Schuster M, Schönegger A, Datlinger P, Kubicek S, Bock C, Kovar H.

Cell Rep. 2015 Feb 24;10(7):1082-95. doi: 10.1016/j.celrep.2015.01.042. Epub 2015 Feb 19.

9.

Mapping the human retina.

Pinz A, Bernögger S, Datlinger P, Kruger A.

IEEE Trans Med Imaging. 1998 Aug;17(4):606-19.

PMID:
9845316
10.

Use of perfluorocarbon liquids in proliferative vitreoretinopathy: results and complications.

Stolba U, Binder S, Velikay M, Datlinger P, Wedrich A.

Br J Ophthalmol. 1995 Dec;79(12):1106-10.

11.

The effect of chemical stability and purification of perfluorocarbon liquids in experimental extended-term vitreous substitution.

Velikay M, Stolba U, Wedrich A, Li Y, Datlinger P, Binder S.

Graefes Arch Clin Exp Ophthalmol. 1995 Jan;233(1):26-30.

PMID:
7721120
12.

Experimental perforating injury with high energy electrons to inhibit intraocular proliferation.

Velikay M, Binder S, Stolba U, Wedrich A, Datlinger P, Handl-Zeller L.

Acta Ophthalmol (Copenh). 1994 Jun;72(3):337-40.

PMID:
7976264
13.

Retinal detachment with severe proliferative vitreoretinopathy in Terson syndrome.

Velikay M, Datlinger P, Stolba U, Wedrich A, Binder S, Hausmann N.

Ophthalmology. 1994 Jan;101(1):35-7.

PMID:
8302561
14.

The antiproliferative effect of fractionized radiation therapy: optimization of dosage.

Velikay M, Stolba U, Wedrich A, Datlinger P, Akramian J, Binder S.

Doc Ophthalmol. 1994;87(3):265-9.

PMID:
7835195
15.

Experimental long-term vitreous replacement with purified and nonpurified perfluorodecalin.

Velikay M, Wedrich A, Stolba U, Datlinger P, Li Y, Binder S.

Am J Ophthalmol. 1993 Nov 15;116(5):565-70.

PMID:
8238215
16.

Irradiation pretreatment before fibroblast implantation in experimental PVR.

Velikay M, Stolba U, Wedrich A, Datlinger P, Binder S, Handl-Zeller L.

Int Ophthalmol. 1993 Aug;17(4):191-3.

PMID:
8112965
17.

Ocular findings in asymptomatic amateur boxers.

Wedrich A, Velikay M, Binder S, Radax U, Stolba U, Datlinger P.

Retina. 1993;13(2):114-9.

PMID:
8337491

Supplemental Content

Loading ...
Support Center